Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 32 | $4,370,443 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Nov 2024 21:31 | REPL | Replimune Group Inc | XYNOS KONSTANTINOS | Chief Medical Officer | 18 Nov 2024 | Sale | 7,246 | 10.78 | 78,112 | D |
20 Nov 2024 21:30 | REPL | Replimune Group Inc | SARCHI CHRISTOPHER | Chief Commercial Officer | 18 Nov 2024 | Sale | 5,207 | 10.78 | 56,131 | D |
19 Aug 2024 20:00 | REPL | Replimune Group Inc | HILL EMILY LUISA | Chief Financial Officer | 16 Aug 2024 | Sale | 8,938 | 10.18 | 90,989 | D |
10 Jun 2024 20:30 | REPL | Replimune Group Inc | XYNOS KONSTANTINOS | Chief Medical Officer | 07 Jun 2024 | Sale | 15,881 | 7.5 | 119,108 | D |
20 May 2024 20:06 | REPL | Replimune Group Inc | SARCHI CHRISTOPHER | Chief Commercial Officer | 16 May 2024 | Sale | 2,218 | 6.47 | 14,350 | D |
20 May 2024 20:06 | REPL | Replimune Group Inc | SCHWENDENMAN ANDREW | Chief Accounting Officer | 16 May 2024 | Sale | 2,298 | 6.47 | 14,868 | D |
20 May 2024 20:05 | REPL | Replimune Group Inc | LOVE COLIN | Chief Operating Officer | 16 May 2024 | Sale | 17,615 | 6.47 | 113,969 | D |
20 May 2024 20:04 | REPL | Replimune Group Inc | ASTLEY-SPARKE PHILIP | Executive Chairman | 16 May 2024 | Sale | 37,928 | 6.47 | 245,394 | D |
20 May 2024 20:02 | REPL | Replimune Group Inc | COFFIN ROBERT | Director | 16 May 2024 | Sale | 11,464 | 6.47 | 74,172 | D |
20 May 2024 20:01 | REPL | Replimune Group Inc | PATEL SUSHIL | Chief Executive Officer | 16 May 2024 | Sale | 20,194 | 6.47 | 130,655 | D |
20 May 2024 20:00 | REPL | Replimune Group Inc | XYNOS KONSTANTINOS | Chief Medical Officer | 16 May 2024 | Sale | 6,367 | 6.47 | 41,194 | D |
17 Nov 2023 20:01 | REPL | Replimune Group Inc | XYNOS KONSTANTINOS | Chief Medical Officer | 16 Nov 2023 | Sale | 7,313 | 10.92 | 79,858 | D |
17 Nov 2023 20:00 | REPL | Replimune Group Inc | SARCHI CHRISTOPHER | Chief Commercial Officer | 16 Nov 2023 | Sale | 5,255 | 10.92 | 57,385 | D |
13 Sep 2023 21:02 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 12 Sep 2023 | Sale | 300 | 20 | 6,000 | D |
13 Sep 2023 21:02 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 11 Sep 2023 | Sale | 5,358 | 20.01 | 107,214 | D |
24 Aug 2023 20:30 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 22 Aug 2023 | Sale | 18,600 | 20.01 | 372,186 | D |
15 Aug 2023 20:30 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 11 Aug 2023 | Sale | 1,400 | 20 | 28,000 | D |
11 Jul 2023 21:00 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 10 Jul 2023 | Sale | 2,077 | 21.12 | 43,866 | D |
11 Jul 2023 21:00 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 10 Jul 2023 | Sale | 17,923 | 21.63 | 387,674 | D |
15 Jun 2023 21:01 | REPL | Replimune Group Inc | LEWIS TANYA | Chief Dev. Op. Officer | 13 Jun 2023 | Sale | 817 | 23.45 | 19,159 | D |
15 Jun 2023 21:01 | REPL | Replimune Group Inc | LEWIS TANYA | Chief Dev. Op. Officer | 13 Jun 2023 | Sale | 12,043 | 24.1 | 290,236 | D |
15 Jun 2023 21:00 | REPL | Replimune Group Inc | PATEL SUSHIL | Chief Strategy Officer | 13 Jun 2023 | Sale | 553 | 23.44 | 12,962 | D |
15 Jun 2023 21:00 | REPL | Replimune Group Inc | PATEL SUSHIL | Chief Strategy Officer | 13 Jun 2023 | Sale | 5,145 | 24.11 | 124,046 | D |
18 May 2023 20:36 | REPL | Replimune Group Inc | PATEL SUSHIL | Chief Strategy Officer | 16 May 2023 | Sale | 15,575 | 18.05 | 281,129 | D |
18 May 2023 20:35 | REPL | Replimune Group Inc | COFFIN ROBERT | President & Chief R&D Officer | 16 May 2023 | Sale | 7,861 | 18.05 | 141,891 | D |
18 May 2023 20:34 | REPL | Replimune Group Inc | LEWIS TANYA | Chief Dev. Op. Officer | 16 May 2023 | Sale | 12,207 | 18.05 | 220,336 | D |
18 May 2023 20:33 | REPL | Replimune Group Inc | LOVE COLIN | Chief Operating Officer | 16 May 2023 | Sale | 10,775 | 18.05 | 194,489 | D |
18 May 2023 20:32 | REPL | Replimune Group Inc | FRANCHI JEAN M. | Chief Financial Officer | 16 May 2023 | Sale | 11,351 | 18.05 | 204,886 | D |
18 May 2023 20:31 | REPL | Replimune Group Inc | XYNOS KONSTANTINOS | Chief Medical Officer | 16 May 2023 | Sale | 771 | 18.05 | 13,917 | D |
18 May 2023 20:31 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 16 May 2023 | Sale | 5,966 | 18.05 | 107,686 | D |
18 May 2023 20:30 | REPL | Replimune Group Inc | ASTLEY-SPARKE PHILIP | Chief Executive Officer | 16 May 2023 | Sale | 17,902 | 18.05 | 323,131 | D |
13 Dec 2022 20:01 | REPL | Replimune Group Inc | ESPOSITO PAMELA | Chief Business Officer | 09 Dec 2022 | Sale | 15,000 | 25.03 | 375,450 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)